A-Rod received therapeutic use exemptions for testosterone for several seasons before Biogenesis hit

41 Comments

There’s a book coming out soon about the Biogenesis scandal. It’s called “Blood Sport: Alex Rodriguez, Biogenesis and the Quest to End Baseball’s Steroid Era” by Tim Elfrink of the Miami New Times and Gus Garcia-Roberts of Newsday. Sports Illustrated is running a very tasty excerpt from it today.

The subject: Alex Rodriguez, not surprisingly. And while part of it is sexy — apparently, the first words out of A-Rod’s mouth to Tony Bosch were “What were you giving Manny Ramiez?” — there’s a more significant and more interesting part of it all too. Specifically: about the many therapeutic use exemptions A-Rod received to legally take testosterone before he hooked up with Biogenesis.

Therapeutic Use Exemptions — or TUEs as they’re often called — allow players to take otherwise banned drugs if they demonstrate a medical need to do so. These days we hear about them most often in connection with stimulants like Adderall, which are used to treat attention deficit disorder. Of course, a far greater percentage of players in Major League Baseball have therapeutic use exemptions for ADD medicine than the population at large has ADD, and for this reasons many look at the TUEs given for them with suspicion. As a means of players to obtain performance enhancing drugs without having to worry about being suspended.

In the book excerpt we learn that A-Rod received multiple TUEs during his time with the Yankees. But they weren’t for ADD medication. They were for testosterone, which is a really damn rare exemption to get. But A-Rod got it:

Before the 2007 season, Rodriguez asked for permission to use testosterone, which has been banned by baseball since 2003. The IPA in ’07 was Bryan W. Smith, a High Point, N.C., physician. (Baseball did not yet have the advisory medical panel.) On Feb. 16, 2007, two days before Rodriguez reported to spring training, Smith granted the exemption, allowing Rodriguez to use testosterone all season.

A-Rod won the MVP that year and, at the end of the year, famously opted out of his Yankees deal and signed his ten-year contract extension. Even after securing what he had to know was his last professional contract, A-Rod continued to apply for and receive TUEs. In 2008 he received a TUE for Clomid, which is similar to the drug that Manny Ramirez got busted for when he was with the Dodgers. A-Rod took it with Major League Baseball’s approval, however.

I’d be pretty interested to learn more about those TUEs A-Rod got. Why he got them when, apparently, a lot of people didn’t. Whether MLB believes it had been too permissive with them back then and whether A-Rod’s decision to quit relying on those and, instead, go an illegal route with Tony Bosch, angered them in some way. I’d also be curious to know if there is a psychological dependency at work with testosterone and other such drugs and whether Major League Baseball approving A-Rod’s use of the stuff contributed to whatever it was that drove A-Rod to continue to take PEDs, long after he ceased to have much if anything to prove on a baseball diamond.

Red Sox, Astros announce lineups for ALCS Game 4

Bob Levey/Getty Images
Leave a comment

Red Sox

RF Mookie Betts
LF Andrew Benintendi
DH J.D. Martinez
SS Xander Bogaerts
3B Rafael Devers
1B Steve Pearce
2B Brock Holt
C Christian Vázquez
CF Jackie Bradley, Jr.

SP Rick Porcello

With Eduardo Núñez banged up, Devers gets another start. Devers has hit well when he’s had an opportunity to play this postseason, registering five hits (all singles) with a pair of walks and a pair of RBI. Pearce gets a start against a right-handed starter. He normally kills lefties but ripped a solo homer off of righty Joe Smith in Game 3. Holt gets the start at second base, looking for his first hit of the ALCS.

Astros

3B Alex Bregman
CF George Springer
DH José Altuve
2B Marwin González
1B Yuli Gurriel
RF Josh Reddick
SS Carlos Correa
C Martín Maldonado
LF Tony Kemp

SP Charlie Morton

Bregman, not Springer, is now hitting leadoff for the Astros. It’s not that Springer has been bad; it’s just that Bregman has been an on-base machine. He has drawn a walk in every postseason game this year, including three in Games 1 and 2 of the ALCS. Morton will be making his first appearance of the 2018 postseason. He was money down the stretch for the Astros last year en route to a championship.